首页> 外文OA文献 >Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy

【2h】

Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy

机译：血液恶性肿瘤患者在完成细胞毒性化疗后撤回先发性拉米夫定后乙肝重新激活

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: The hepatic outcome of hepatitis B surface antigen (HBsAg) positive patients undergoing chemotherapy after withdrawal of pre-emptive lamivudine is unknown.

机译：背景：撤回先发性拉米夫定后接受化疗的乙肝表面抗原（HBsAg）阳性患者的肝结局尚不清楚。

著录项

作者
Hui, C-K; Cheung, W W W; Au, W-Y; Lie, A K W; Zhang, H-Y; Yueng, Y-H; Wong, B C Y; Leung, N; Kwong, Y-L; Liang, R; Lau, G K K;
展开▼
作者单位

展开▼
年度 2005
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy [J] . Marrone A., Capoluongo N., DAmore C., Journal of viral hepatitis. . 2018,第2期

机译：18个月的拉米夫定预防预防隐匿性乙型肝炎病毒感染重新激活的患者患有免疫抑制治疗的血液恶性肿瘤
2. Hepatitis B virus reactivation in hepatitis B surface antigen seropositive patients with metastatic non-small cell lung cancer receiving cytotoxic chemotherapy: the efficacy of preemptive lamivudine and identification of risk factors [J] . Lin Gui-Nan, Peng Jie-Wen, Xiao Jian-Jun, Medical oncology . 2014,第8期

机译：转移性非小细胞肺癌转移性非小细胞肺癌接受细胞毒性化疗的乙型肝炎表面抗原血清阳性患者的乙型肝炎病毒重新激活：拉米夫定抢先的疗效和危险因素的识别
3. Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis-B surface antigen (HBSAG) seropositive cancer patients undergoing cytotoxic chemotherapy. [J] . Cil T, Altintas A, Pasa S, Leukemia and lymphoma . 2008,第5期

机译：拉米夫定可预防正在接受细胞毒性化疗的B型肝炎表面抗原（HBSAG）血清反应阳性的癌症患者的B型肝炎病毒再激活。
4. Chemotherapy Changes Cytotoxic Activity of NK-cells in Cancer Patients [C] . M. Stakheyeva, N. Yunusova, M. Patysheva, International Conference on Physics of Cancer : Interdisciplinary Problems and Clinical Applications . 2017

机译：化疗改变了癌症患者中NK细胞的细胞毒性活性
5. Hepatitis virus reactivation in cancer patients undergoing cytotoxic chemotherapy: Incidences, associated factors and management. [D] . Yeo, Winnie. 2001

机译：接受细胞毒性化学疗法治疗的癌症患者的肝炎病毒再激活：发生率，相关因素和管理。
6. Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy [O] . C-K Hui, W W W Cheung, W-Y Au, 2005

机译：血液系统恶性肿瘤患者在完成细胞毒性化疗后撤回先发拉米夫定后乙肝重新活化
7. Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy [O] . Lie AKW, Kwong YL, Leung N, 2005

机译：完成细胞毒性化疗后，血液系统恶性肿瘤患者戒断前拉米夫定后乙型肝炎再激活

Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy

摘要

著录项

相似文献

相关主题

期刊订阅